Analysts predict profit of $1.51 per share for West Pharmaceutical Services in Q2 2025.

West Pharmaceutical Services, Inc. (WST), valued at $16 billion, is a global leader in packaging and delivery systems for injectable drugs. Analysts predict a profit of $1.51 per share in the upcoming fiscal second-quarter earnings report, slightly down from last year. Despite a 30.7% drop in shares over the past year, the company exceeded revenue expectations in the first quarter. Analysts are bullish on WST, with a majority rating it as a “Strong Buy.” The average analyst price target is $279.55, suggesting a potential upside of 25.8% from current levels.

Read more at Yahoo Finance: West Pharmaceutical Services’ Q2 2025 Earnings: What to Expect